Who Just RaisedFort Lauderdale, FL · Health Care · Form D filed Aug 31, 2026
Lurex Bio, Inc. raised $150K
Lurex Bio, Inc. is a biotechnology company based in Fort Lauderdale, Florida. In an amended Form D filed with the SEC on August 31, 2026, it reported raising $150,000 from 3 investors as part of an offering of indefinite size. The first sale in the offering took place on January 22, 2026.
LurexBio is developing a non genetic, non viral recognition engineering platform to address an important component of tumor immune evasion in immune cold cancers.
- 2nd Form D since 2026. Earlier new notices: Feb 5, 2026. All filings on EDGAR
- Open-ended round. The offering has no stated size limit.
- Rule 506(c) offering. The company may advertise this round publicly; buyers must be verified accredited investors.
$150K raised since 2020
1 Form D offering, as reported to the SEC. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Feb 5, 2026 | $150K | Open | 3 |
Lead score
31 out of 100
early raise still raising website found young company
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Website
- lurexbio.com
- Amount raised
- $150,000
- Offering size
- Indefinite
- Investors so far
- 3
- Minimum investment
- $50,000
- First sale
- January 22, 2026
- Securities offered
- Equity, Debt
- Exemption claimed
- Rule 506(c)
- Industry
- Biotechnology
- Headquarters
- Fort Lauderdale, Florida
- Incorporated
- Delaware, 2025
- Entity type
- Corporation
- Revenue range
- No Revenues
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D/A (amendment) | $150,000 | Indefinite | 3 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Aug 31, 2026 · Health Care funding in Florida · August 2026 funding report
Similar raises
Equidefi Ltd.
Fort Lauderdale, FL · filed Oct 1
EquiDeFi® is a revolutionary new choice for launching and managing private offerings. Designed with SEC compliance foremost in mind.
3rd Form D since 2022Still raising
Debit My Data, Inc.
Fort Lauderdale, FL · filed Sep 32nd Form D since 2024Still raising
Kaida BioPharma Inc.
Fort Lauderdale, FL · filed Sep 13rd Form D since 2023Still raising
USA Made in America Inc.
Fort Lauderdale, FL · filed Aug 20First Form DStill raising
Immorta Bio, Inc.
Miami Beach, FL · filed Oct 162nd Form D since 2026Still raising
Curadel Surgical Innovations, Inc.
Bonita Springs, FL · filed Oct 134th Form D since 2023Still raising
BioStem Technologies, Inc.
Pompano Beach, FL · filed Oct 9
BioStem Technologies® produces innovative perinatal tissue-based allografts, including VENDAJE®, VENDAJE AC® and VENDAJE® optic.
7th Form D since 2016
Lev 18, Inc.
Surfside, FL · filed Oct 9First Form D